ArticleScience translational medicine2021

Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease.

Annalisa Lattanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.